Singapore, May 19 -- AITRICS, a medical artificial intelligence (AI) startup in South Korea, has obtained medical device approval from the Medical Device Authority(MDA) of Malaysia for its AI solution for patient deterioration prediction, AITRICS-VC(VitalCare).

AITRICS-VC(VitalCare) is a medical AI solution that leverages electronic medical record (EMR) data from hospitals to predict patient deterioration at an early stage. This marks the sixth regulatory approval for AITRICS-VC(VitalCare), including Korea, further strengthening the company's foundation for global market expansion, including Southeast Asia, following its approval in Indonesia last month.

The approval obtained in Malaysia falls under Class C according to Malaysia's medic...